Close
CDMO Safety Testing 2026
Novotech

Press Releases

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics, the worldโ€™s leading contract development and manufacturing organization, signed a strategic partnership with KAHR Medical Ltd., a cancer immunotherapy company developing novel multifunctional immune-recruitment proteins. Under the terms of the agreement, Samsung Biologics will provide its end-to-end...

ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain

Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India...

Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

Pfizer Inc and BioNTech SEย  announced that the Conditional Marketing Authorization (CMA) for COMIRNATYยฎ in the European Union (EU) has been expanded to include individuals 12 to 15 years of age. This follows the European Medicines Agencyโ€™s (EMA) Committee...

Medpharm Opens State Of The Art Manufacturing Facility in Durham, NC (RTP)

MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, is opening a new location in Raleigh-Durham, North Carolina that will expand its CDMO services in topical and transdermal delivery. Doubling its existing footprint, the facility will support...

Aptamer and PinotBio collaborate to develop new therapeutic drug conjugates

Aptamer Group Limited, the developer of Optimerโ„ข Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, announce that they have entered into a strategic collaboration agreement. The agreement is to develop Optimer-drug conjugates for targeted drug delivery combining...

Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,ย  announced that it has entered into an agreement with Thermo Fisher Scientific for fill/finish sterile manufacturing services and supply packaging for Modernaโ€™s COVID-19 vaccine. Under the terms...

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a new...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป